Liqiong Yang, Fan Xu, Fangfang Liu, Shu Yang, Yuxi Duan
{"title":"我们对晚期胰腺癌是否使用了合适的治疗方案?","authors":"Liqiong Yang, Fan Xu, Fangfang Liu, Shu Yang, Yuxi Duan","doi":"10.31487/J.DDA.2019.01.01","DOIUrl":null,"url":null,"abstract":"Even through numerous combinations of chemotherapy regimens are used to treat on the advanced pancreatic cancer, APC; however, the survival rate (overall survival and progress free survival) and treatment-related toxicity remain challenge. Here we provided neutral and failed outcomes that treat the APC in clinical trials, this need us to think twice whether we were used the appropriate therapy regimens, to enlarge the survival rate and to reduce the treatment-related toxicity. Evidences of treatment on APC are need indeed to assistant our physician decision making correctly.","PeriodicalId":250883,"journal":{"name":"Drug and Drug Abuse","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Are we used the appropriate therapy regimens on advanced pancreatic cancer?\",\"authors\":\"Liqiong Yang, Fan Xu, Fangfang Liu, Shu Yang, Yuxi Duan\",\"doi\":\"10.31487/J.DDA.2019.01.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Even through numerous combinations of chemotherapy regimens are used to treat on the advanced pancreatic cancer, APC; however, the survival rate (overall survival and progress free survival) and treatment-related toxicity remain challenge. Here we provided neutral and failed outcomes that treat the APC in clinical trials, this need us to think twice whether we were used the appropriate therapy regimens, to enlarge the survival rate and to reduce the treatment-related toxicity. Evidences of treatment on APC are need indeed to assistant our physician decision making correctly.\",\"PeriodicalId\":250883,\"journal\":{\"name\":\"Drug and Drug Abuse\",\"volume\":\"79 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and Drug Abuse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31487/J.DDA.2019.01.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Drug Abuse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/J.DDA.2019.01.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Are we used the appropriate therapy regimens on advanced pancreatic cancer?
Even through numerous combinations of chemotherapy regimens are used to treat on the advanced pancreatic cancer, APC; however, the survival rate (overall survival and progress free survival) and treatment-related toxicity remain challenge. Here we provided neutral and failed outcomes that treat the APC in clinical trials, this need us to think twice whether we were used the appropriate therapy regimens, to enlarge the survival rate and to reduce the treatment-related toxicity. Evidences of treatment on APC are need indeed to assistant our physician decision making correctly.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
